As per the report titled ‘Left Atrial Appendage Closure Devices Market Size By Product, By Procedure, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026’, available with Market Study Report, global left atrial appendage closure devices market is expected to register significant traction during 2020-2026.
 

The surging pervasiveness of AF (atrial fibrillation) and technological advancements are driving the remuneration graph of left atrial appendage closure devices market across the globe. Left atrial appendage (LAA) is an ear-shaped sac present within the muscle wall of the left atrium in the heart.
 

Normally, the heart contracts with heartbeats, and the blood in left atrial appendage and left atrium is pushed into the left ventricle out of the left atrium. In patients with atrial fibrillation, electric impulses controlling the heartbeat cannot travel normally through the heart. Rather, various impulses occur concurrently, spreading through the atria. The disorganized impulses fail to provide adequate time to squeeze blood into the ventricles.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2696878/
 

Left atrial appendage being a small pouch, results in blood collection, which can possibly lead to clot formation in the atria and left atrial appendage. Individuals having atrial fibrillation are more exposed to a stroke as compared to others.
 

Several devices have been tested and proposed for the efficacy and safety to treat this ailment. Devices such as the WATCHMAN, the LARIAT, the PLAATO system, and the Amplatzer Cardiac Plug among others have been the most studied devices. These devices require minimum skin wounding and are embedded using endovascular techniques.
 

The left atrial appendage closure devices market is segmented based on product terrain, procedure gamut, end-use spectrum, and regional landscape.
 

Based on the product terrain, the market is segmented in terms of endocardial left atrial appendage, and epicardial left atrial appendage. The latter segment is anticipated to register 26.4% CAGR during the analysis timeframe.
 

Speaking of procedure gamut, surgical procedure segment is reckoned to witness a CAGR of 27% over the forecast time period.
 

Elaborating on end-use spectrum, the market is segmented into hospitals, ambulatory surgery centers, and others. Among these, ambulatory surgery centers segment was worth nearly $92 million in 2019 and is expected to grow substantially in the ensuing years.
 

From a geographical point of view, Latin America LAA closure devices market was worth more than $9.1 million in 2019 and is expected to expand recording a CAGR of over 24% during the analysis timeframe. Parallelly, Middle East & Africa LAA closure devices market was estimated to hold a value of over $7.5 million in 2019 and is poised to register a CAGR of over 23% through 2026.
 

Abbott, Boston Scientific, Lifetech Scientific, Articure, Johnson and Johnson, and Occlutech among others are leading companies in global left atrial appendage closure devices market.